SCHWARTZ MARK W. 4
4 · Galena Biopharma, Inc. · Filed Jan 9, 2012
Insider Transaction Report
Form 4
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
- Other
Common Stock, par value $.0001
2011-12-31$0.40/sh+12,924$5,170→ 350,585 total
Footnotes (1)
- [F1]Pursuant to the Issuer's Employee Stock Purchase Plan.